Prostate Cancer Foundation (US)
Since its establishment in 1993, the Prostate Cancer Foundation (PCF) has been firmly committed to curing prostate cancer. The PCF's unique strategies for identifying and investing in the most promising research programs have generated life-saving results, and have seen the foundation grow into a leading philanthropic organisation, funding, and accelerating research globally.
The PFC channels resources to the world’s top scientific minds and as a champion for increased government and private support, has helped build a global research enterprise of nearly $10 billion. Through the generous contributions of its donors, the Foundation has funded more than 2,000 programs at more than 200 research centers in 18 countries.
PCF also act as a primary source for new standard-of-care and research information for more than 16 million men and their families fighting prostate cancer globally, . The Foundation connects patients, loved ones, care providers, and scientists to critical updates, the latest developments, best practices and news from the treatment pipeline.
PCF funding or coordination has resulted in many important discoveries in the fight against prostate cancer since 1993—including the development of new medications, gene therapy approaches and the development of vaccines that may soon work with the body’s immune system to kill prostate cancer cells.
